Opeyemi Awoyemi

UiT The Arctic University of Norway

Papers

1

Total Citations

14

H-Index

1

About

Opeyemi Awoyemi’s research centers on advancing drug discovery methodologies, with a particular focus on improving the prediction of oral drug absorption through innovative in vitro screening techniques. His most notable contribution is the development and automation of the phospholipid vesicle-based drug permeability assay, a breakthrough that enables high-throughput screening of passive drug absorption in humans. This work, detailed in his highly cited 2008 paper, addresses a critical bottleneck in pharmaceutical development by providing a more reliable and efficient alternative to traditional permeability tests. With 14 citations, this study has influenced subsequent efforts to streamline drug candidate evaluation. Awoyemi’s achievements reflect a commitment to bridging the gap between laboratory assays and clinical relevance, offering researchers a robust tool for early-stage drug selection. His contributions are particularly valuable for students and scientists in pharmacokinetics and drug design, as they underscore the importance of predictive models in reducing costly late-stage failures. Through this work, Awoyemi has helped shape modern approaches to permeability screening, making him a key figure in the evolution of drug discovery technologies.

Research Focus

Key Achievements

1
H-Index
1
Papers
14
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
The Phospholipid Vesicle-Based Drug Permeability Assay: 5. Development toward an Automated Procedure for High-Throughput Permeability Screening
14 citations · 2008
📈 Most Prolific Year: 2008 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: UiT The Arctic University of Norway

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago